+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Dynavax Technologies Corporation - logo

Dynavax is a clinical-stage biopharmaceutical company with multiple product candidates in development for the treatment of autoimmune and inflammatory diseases, and the treatment of cancer. The company’s lead product candidates include HEPLISAV-B, an investigational adult hepatitis B vaccine; and AZD1419, which is in Phase II clinical trial for the treatment of asthma. Dynavax Technologies Corporation was founded in 1996 and is headquartered in Berkeley, California.

From
Autoimmune Hepatitis Pipeline Insight, 2019 - Product Thumbnail Image

Autoimmune Hepatitis Pipeline Insight, 2019

  • Drug Pipelines
  • 60 Pages
From
From
From
From
Hepatitis B - Pipeline Review, H2 2019 - Product Thumbnail Image

Hepatitis B - Pipeline Review, H2 2019

  • Drug Pipelines
  • 476 Pages
From
From
From
From
From
Melanoma - Pipeline Review, H2 2018 - Product Thumbnail Image

Melanoma - Pipeline Review, H2 2018

  • Drug Pipelines
  • 2285 Pages
From
Melanoma - Pipeline Review, H1 2018 - Product Thumbnail Image

Melanoma - Pipeline Review, H1 2018

  • Drug Pipelines
  • 2011 Pages
From
Loading Indicator
adroll